new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Ipsen Pharma S a s
Ipsen Pharma S a s_20100107
  

Ipsen Pharma S a s patents

Recent patent applications related to Ipsen Pharma S a s. Ipsen Pharma S a s is listed as an Agent/Assignee. Note: Ipsen Pharma S a s may have other listings under different names/spellings. We're not affiliated with Ipsen Pharma S a s, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Ipsen Pharma S a s-related inventors




Date Ipsen Pharma S a s patents (updated weekly) - BOOKMARK this page
02/09/17Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
02/09/17Composition and methods for stimulating gastrointestinal motility
12/22/16Melanocortin receptor ligands
12/08/16Use of melanocortins to treat insulin sensitivity
11/24/16Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
11/03/16Novel imidazolidine-2,4-dione derivatives
11/03/16Novel imidazolidine-2,4-dione derivatives
10/27/16Growth hormone releasing peptides
08/04/16Pharmaceutical compositions of growth hormone secretagogue receptor ligands
07/21/16Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
06/30/16Aqueous sustained release compositions of lhrh analogues
06/23/16Melanocortin receptor ligands modified with hydantoin
06/02/16Pharmaceutical composition for a sustained release of lanreotide
02/04/16Macrocyclic lrrk2 kinase inhibitors
01/07/16Novel purifying polyesters
12/24/15Use of melanocortins to treat insulin sensitivity
10/15/15Macrocyclic lrrk2 kinase inhibitors
10/15/15Somatostatin-dopamine chimeric analogs
09/10/15Somatostatin analogs and dimers thereof
09/10/15Analogues of glucose-dependent insulinotropic polypeptide
09/10/15Glucose-dependent insulinotropic polypeptide analogues
08/27/15Thiazole derivatives for treating dyskinesias caused by a chemical treatment
08/06/15Composition and methods for stimulating gastrointestinal motility
06/25/15Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
06/11/15Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
05/28/15Somatostatin-dopamine chimeric analogs
04/23/15Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
01/29/15Growth hormone releasing peptides
01/01/15Sustained release formulations comprising gnrh analogues
12/25/14Flavoured clay-based therapeutic composition
06/05/14Therapeutic use of botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
05/15/14Ghrelin analogs
05/01/14Somatostatin-dopamine chimeric analogs
02/27/14Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof
01/09/14Melanocortin receptor ligands modified with hydantoin
11/28/13Method for the preparation of plymers with varied archtecture and amide initiation
09/26/13Novel octapeptide compounds and therapeutic use thereof
08/15/13Pharmaceutical compositions of growth hormone secretagogue receptor ligands
05/16/13Growth hormone releasing peptides
03/28/13Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
03/07/13Clay compositions
02/14/13Use of clays for treating coeliac disease
12/20/12Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereof
12/13/12Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/01/12Glp-1 pharmaceutical compositions
10/25/12Formulation for hgh and rhigf-1 combination
09/06/12Pharmaceutical compositions of melanocortin receptor ligands
09/06/12Process for the synthesis of ac-arg-cyclo(cys-d-ala-his-d-phe-arg-trp-cys)-nh2
08/09/12Sustained release formulations comprising gnrh analogues
07/26/12Analogues of insulin-like growth factor-1 (igf-1) having amino acid substitution at position 59
05/31/12Use of melanocortins to treat dyslipidemia
04/19/12Imidazolidine-2,4-dione derivatives and use thereof as a medicament
04/05/12Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
03/29/12Glp-1 analogues pharmaceutical compositions
07/14/11Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
04/21/11Method of drug delivery for bone anabolic protein
03/10/114-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands
03/03/11Novel catalytic systems for the ring-opening (co)polymerization of lactones
02/17/11Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
02/10/11Liquid and freeze dried formulations
12/16/104,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses
10/07/10Pyrimido-benzimidzole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
09/02/10Pyrazolo-pyrazines derivatives used as g protein inhibitors
08/19/10Sustained release formulations comprising very low molecular weight polymers
06/03/10Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
Patent Packs
03/04/10Phenyl derivatives and their use as a medicament
02/04/10Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the aids virus
01/07/10Use of clays for treating coeliac disease
12/31/09Pyrimidinone derivatives and their use as a drug
10/29/09Product comprising a transduction inhibitor of heterotrimeric g protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer
01/07/10Use of clays for treating coeliac disease







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ipsen Pharma S a s in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ipsen Pharma S a s with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';